Trevi Therapeutics, Inc. TRVI Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Trevi Therapeutics, Inc. (TRVI) reported operating lease right-of-use assets in other assets of $610K in Q1 2026.
- How has Trevi Therapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Trevi Therapeutics, Inc.'s operating lease right-of-use assets in other assets decreased by 29.5% year-over-year, from $865K to $610K.
- What is the long-term trend for Trevi Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s operating lease right-of-use assets in other assets has grown at a 24.4% compound annual growth rate (CAGR), from $227K to $677K.